Memorial Şişli Hospital
Neuroblastoma treatment cost in Turkey typically includes complex diagnostics ranges from $1,600 to $1,900 and primary therapeutic interventions like complex treatment of neuroblastoma which runs from $28,000 to $42,000. Total expenses depend on the tumor stage, required surgery, and the number of chemotherapy cycles. Patients can save approximately 40-70% compared to US medical prices by choosing JCI-accredited facilities in Istanbul, Ankara, or Gebze.
Typical Neuroblastoma Treatment Costs in Turkey
Bookimed Expert Insight: For high-risk neuroblastoma requiring multidisciplinary care, Anadolu Medical Center provides American-standard protocols through its Johns Hopkins affiliation. Families seeking advanced cellular therapies find specialized expertise at Medipol Mega University Hospital, which earned the Bookimed 2019 award for pediatric cancer treatment. Memorial Şişli Hospital is a top choice for patients needing bone marrow transplants, boasting professional teams with JCI accreditation and high organ transplant success rates.
| Turkey | Austria | Spain | |
| Complex treatment of neuroblastoma | from $28,000 | from $180,000 | from $70,000 |
Prof. Ceyhun Bozkurt is a pediatric oncology specialist with advanced training in neuroblastoma at Harvard's Dana-Farber Cancer Institute.
Prof. Ahmet Demir specializes in pediatric cancers, with focused on treating neuroblastoma at Memorial Ankara Hospital.
Prof. Yıldırım has published over 80 oncology works and co-authored a handbook on advanced cancer care. She is an expert in immunotherapy and targeted therapies.
Dr. Ahmet Nadir Tosyali is a pediatric surgeon at Anadolu Medical Center in Istanbul. He holds the Turkish Pediatric Surgery Qualification Certificate. Dr. Tosyali treats complex conditions like Wilms tumor, neuroblastoma, and spina bifida. He provides care at a clinic affiliated with Johns Hopkins Medicine.
Reputable Turkish hospitals for neuroblastoma include JCI-accredited centers like Anadolu Medical Center and Memorial Sisli Hospital. These facilities offer advanced immunotherapy and bone marrow transplants. Specialist teams use MIBG-scintigraphy and genetic research to stage high-risk pediatric cases for personalized treatment plans.
Bookimed Expert Insight: Anadolu Medical Center stands out because of its formal affiliation with Johns Hopkins Hospital. This ensures international standards for complex procedures. Our data shows it treats 65,000 patients annually. For neuroblastoma, this high volume is vital. It means the surgical and oncology teams handle rare cases frequently. This leads to better outcomes in staging and tumor resection.
Patient Consensus: Parents find quick diagnostic staging a major relief during the initial stressful weeks. They recommend choosing large centers with dedicated pediatric ICUs and in-house translators to manage long-term treatment logistics.
Turkish pediatric centers report a 5-year survival rate around 68% for high-risk neuroblastoma. Lower-risk cases achieve survival rates up to 98% following international protocols. Specialized clinics utilize autologous stem cell transplants and CAR NK cell therapy to improve outcomes for children with advanced-stage disease.
Bookimed Expert Insight: Quality signals for pediatric oncology in Turkey often correlate with high patient volumes and specialized certifications. For example, Medipol Mega University Hospital serves over 1,000,000 patients annually and was ranked specifically as the best clinic for pediatric cancer by Bookimed patients. Choosing a center with these specific volume-based credentials ensures access to experienced teams like those under Dr. Ceyhun Bozkurt, who trained at Harvard and Cincinnati Children’s.
Patient Consensus: Parents note that staging and diagnostic tests are performed very quickly in Istanbul. They emphasize that working with a high-volume team is essential for managing the uncertainty of a high-risk diagnosis.
Turkey offers advanced immunotherapy for high-risk neuroblastoma at specialized oncology centers. Treatment protocols often include CAR T-cell therapy and monoclonal antibodies. JCI-accredited hospitals in Istanbul provide these therapies alongside pediatric bone marrow transplants. Patients access these treatments through multidisciplinary teams of pediatric oncologists and surgeons.
Bookimed Expert Insight: Clinical data shows a concentration of neuroblastoma expertise in Istanbul. Prof. Dr. Ceyhun Bozkurt has published over 40 peer-reviewed studies on neuroblastoma. Centers like Medipol Mega serve over 1,000,000 patients annually. This high volume allows these facilities to maintain steady supplies of biological drugs. Choosing these large university-affiliated hospitals ensures access to the latest cell therapies.
Patient Consensus: Parents clarify that confirming anti-GD2 antibody availability is essential before starting the maintenance phase. Patients note that specialized centers in Istanbul provide fast staging and simple explanations of risk categories.
Neuroblastoma treatment in Turkey follows a multidisciplinary journey spanning 12 to 15 months. It integrates molecular diagnostics with intensive therapies like autologous stem cell transplants. Turkish centers utilize JCI-accredited protocols to manage high-risk cases. Treatment includes induction chemotherapy, surgical resection, and advanced immunotherapy.
Bookimed Expert Insight: Turkish oncology centers often lead in volume, with Medipol Mega treating 1,200 patients daily. Our data shows a pattern where top specialists like Prof. Dr. Ceyhun Bozkurt combine stem cell expertise with neuroblastoma care. This double specialization is vital. It ensures the transition from induction chemo to transplant is seamless within the same facility.
Patient Consensus: Parents note that staging and scans happen very quickly in Istanbul. This speed provides relief during a high-stress diagnosis period. They appreciate having dedicated translators who stay with them throughout the entire medical journey.
Turkish hospitals provide extensive international support services through dedicated departments. Facilities like Anadolu Medical Center and Memorial Health Group offer multilingual translation and logistics assistance. These services ensure seamless medical coordination for oncology patients traveling from over 160 countries for complex care.
Bookimed Expert Insight: Anadolu Medical Center maintains a unique advantage through its Johns Hopkins affiliation. This partnership ensures that international administrative protocols match American standards. Our data shows this consistency is vital for neuroblastoma cases requiring complex MIBG-scintigraphy and multidisciplinary pediatric oncology coordination.
Patient Consensus: Patients note that having a fixed translator and on-site currency exchange makes arriving in Istanbul much easier. They appreciate when clinics explain complex risk categories in simple terms during the staging process.
International families choose Turkey for neuroblastoma care. The country offers high-volume paediatric oncology centres and access to therapies. Leading hospitals provide specialised bone marrow transplants, immunotherapy, and robotic surgery. These come at a fraction of the cost found in the United States or Western Europe.
Bookimed Expert Insight: Turkey has a unique concentration of paediatric bone marrow units within general oncology centres. Hisar Hospital Intercontinental, for example, treats 250,000 patients annually. It offers allogeneic, autologous, and haploidentical transplants in HEPA-filtered rooms. This infrastructure allows specialists to move from initial chemotherapy to stem cell rescue. There is no need to transfer the child between facilities.
Patient Consensus: Patients note that staging and scans happen very quickly in Turkey. This provides relief during a time-sensitive diagnosis. Families appreciate the fixed translators and friendly staff. They help navigate the journey from the airport to the operating theatre.
Turkish specialists treat neuroblastoma using a risk-adapted multimodal strategy. They combine surgery, high-dose chemotherapy, and autologous stem cell transplantation. Specialised clinics use targeted immunotherapy and radiotherapy to clear residual disease. These protocols align with international standards like the Children's Oncology Group (COG) for paediatric care.
Bookimed Expert Insight: Turkish paediatric oncology stands out due to the high volume of complex stem cell transplants. Hisar Hospital Intercontinental alone treats 250,000 patients annually and operates a specialised bone marrow unit with HEPA-filtered rooms. This infrastructure is vital for neuroblastoma patients. Consolidation therapy requires a sterile environment to prevent infections while the immune system recovers.
Patient Consensus: Patients note that staging tests like PET-CT and MIBG scans are performed quickly in Istanbul. Families value the multidisciplinary tumour boards where surgeons and oncologists collaborate to explain the child's risk category in simple terms.
High-risk neuroblastoma treatment in Turkey follows a standardised 18-month roadmap. It involves induction chemotherapy, surgical resection, and consolidation via bone marrow transplant. Major JCI-accredited centres use MIBG-scintigraphy and PET-CT to monitor progress. Examples include Memorial Ankara Hospital and Anadolu Medical Center. This intensive approach maintains high 5-year survival rates for paediatric cases.
Bookimed Expert Insight: Turkish oncology centres often provide a clinical advantage by hosting multidisciplinary tumour boards that include paediatric surgeons like Dr Ahmet Nadir Tosyali. Centres such as Hisar Hospital Intercontinental perform allogeneic and haploidentical transplants, which are critical if a child’s own stem cells are not viable. This integrated approach means the entire roadmap occurs within one facility.
Patient Consensus: Families in Turkey emphasise the speed of staging tests and the clarity of risk-category explanations. They note that having an English-speaking coordinator helps manage the long-term transition. This transition goes from surgery to maintenance therapy.